Lista de obras - S. Vincent Rajkumar - Dominio Público Uruguay

6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance

artículo científico publicado en 2006

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

artículo científico publicado en 2016

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A classic case of amyloid cardiomyopathy

artículo científico publicado en 2012

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

artículo científico publicado en 2011

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

artículo científico publicado en 2013

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2002

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

artículo científico publicado en 2008

A phase 2 study of bortezomib in relapsed, refractory myeloma

artículo científico publicado en 2003

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

artículo científico publicado en 2005

A phase II trial of imatinib in patients with refractory/relapsed myeloma

artículo científico publicado en 2006

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

artículo científico publicado en 2012

A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans.

artículo científico publicado en 2012

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

artículo científico publicado en 2007

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

artículo científico publicado en 2006

A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma.

artículo científico publicado en 2000

A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies

artículo científico publicado en 2002

A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.

artículo científico publicado en 2000

A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer

artículo científico publicado en 1998

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

scientific article published on 14 April 2020

A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.

artículo científico publicado en 2013

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.

artículo científico publicado en 2007

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.

artículo científico publicado en 2015

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

artículo científico publicado en 2006

Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

artículo científico publicado en 2004

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

artículo científico publicado en 2012

Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence

artículo científico publicado en 2010

Advances in the treatment of amyloidosis

artículo científico publicado en 2007

Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance

artículo científico publicado en 2013

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma

artículo científico publicado en 2018

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration

artículo científico publicado en 2013

Anemia After Orchiectomy

artículo científico publicado en 1998

Angiogenesis in Waldenstrom's macroglobulinemia

artículo científico publicado en 2003

Angiogenesis in multiple myeloma

artículo científico publicado en 2001

Anti-CD20 monoclonal antibody therapy in multiple myeloma.

artículo científico publicado en 2008

Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.

artículo científico publicado en 2012

Approach to the treatment of multiple myeloma: a clash of philosophies.

artículo científico publicado en 2011

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

artículo científico publicado en 2019

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

artículo científico publicado en 2010

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy

artículo científico publicado en 2008

Autologous stem cell transplant for multiple myeloma patients 70 years or older

artículo científico publicado en 2016

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis

artículo científico publicado en 2008

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

artículo científico publicado en 2016

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma

artículo científico publicado en 1999

BiTEing the Tumor

artículo científico publicado en 2020

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study

artículo científico publicado en 2002

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

artículo científico publicado en 2020

Bone marrow angiogenesis and circulating plasma cells in multiple myeloma

scientific article published on 01 July 2003

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis

scientific article published on 01 July 2002

Bone marrow angiogenesis in multiple myeloma: effect of therapy

article

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

artículo científico publicado en 1999

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.

artículo científico publicado en 2004

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

artículo científico publicado en 2011

Bortezomib combination therapy in multiple myeloma

artículo científico publicado en 2012

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

artículo científico publicado en 2016

Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

artículo científico publicado en 2010

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

scholarly article by M Hasib Sidiqi et al published 8 November 2018 in Blood Cancer Journal

Bortezomib-induced acute interstitial nephritis

artículo científico publicado en 2015

CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations

artículo científico publicado en 2005

Cancer symposium for the practitioner: introduction to solid tumors

artículo científico publicado en 2007

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

article

Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature

artículo científico publicado en 2017

Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments

artículo científico publicado en 2004

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

artículo científico publicado en 2011

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

artículo científico publicado en 2017

Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma

artículo científico publicado en 2008

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma.

artículo científico publicado en 2015

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

artículo científico publicado en 2019

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Chemotherapy-associated thrombosis.

artículo científico publicado en 2009

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

artículo científico publicado en 2003

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

artículo científico publicado en 2002

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

artículo científico publicado en 2005

Circulating serum free light chains as predictive markers of AIDS-related lymphoma

artículo científico publicado en 2010

Clarification of the definition of complete response in multiple myeloma

scientific article published on 21 October 2015

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

artículo científico publicado en 2010

Clinical Course and Prognosis of Non-Secretory Multiple Myeloma

artículo científico publicado en 2015

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

article

Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies

artículo científico publicado en 2016

Clinical Trial End Points in Severe COVID-19

artículo científico publicado en 2020

Clinical and biological significance of RAS mutations in multiple myeloma.

artículo científico publicado en 2008

Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both

artículo científico publicado en 2015

Clinical characteristics and outcomes in biclonal gammopathies

artículo científico publicado en 2016

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

artículo científico publicado en 2020

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

artículo científico publicado en 2016

Clinical course and prognosis of non-secretory multiple myeloma

artículo científico publicado en 2015

Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study

artículo científico publicado en 2014

Clinical course of patients with relapsed multiple myeloma

artículo científico publicado en 2004

Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma

artículo científico publicado en 2005

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma ⬇️

artículo científico publicado en 2010

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis

scientific article published on 05 March 2019

Clinical impact of discordance in serum albumin measurements on myeloma international staging system

artículo científico publicado en 2008

Clinical implication of centrosome amplification in plasma cell neoplasm

artículo científico publicado en 2005

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

artículo científico publicado en 2009

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project

artículo científico publicado en 2018

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

artículo científico publicado en 2017

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

artículo científico publicado en 2017

Clinical significance of TP53 mutation in myeloma

artículo científico publicado en 2007

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

scientific article published on 17 February 2017

Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.

artículo científico publicado en 2009

Clinically relevant end points and new drug approvals for myeloma

artículo científico publicado en 2007

Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies

scientific article published on 13 March 2012

Clonal competition with alternating dominance in multiple myeloma.

artículo científico publicado en 2012

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

artículo científico publicado en 2013

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Combination Chemotherapy with Cisplatin, Carboplatin, and Etoposide in Advanced Malignancy ⬇️

artículo científico publicado el 1 de octubre de 1997

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

artículo científico publicado en 2005

Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial

artículo científico publicado en 2005

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

artículo científico publicado en 2002

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

artículo científico publicado en 2012

Community-Based Study of Celiac Disease Autoimmunity Progression in Adults

scientific article published on 24 September 2019

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of bromcresol green and agarose protein electrophoresis for quantitation of serum albumin in multiple myeloma

artículo científico publicado en 2007

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

artículo científico publicado en 2010

Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

artículo científico publicado en 2015

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

artículo científico publicado en 2011

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

artículo científico publicado en 2011

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

artículo científico publicado en 2011

Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trial

artículo científico publicado en 2008

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

artículo científico publicado en 2013

Controversies regarding the use of dexamethasone in patients with multiple myeloma.

artículo científico publicado en 2008

Conventional therapy and approach to management

artículo científico publicado en 2005

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

artículo científico publicado en 2020

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

artículo científico publicado en 2020

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

artículo científico publicado en 2009

Current therapy for multiple myeloma

artículo científico publicado en 2002

Current, Emerging, and Anticipated Therapies for Sickle Cell Disease

artículo científico publicado en 2018

Cytogenetic Abnormalities Correlate with the Plasma Cell Labeling Index and Extent of Bone Marrow Involvement in Myeloma

article

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

artículo científico publicado en 2019

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

artículo científico publicado en 2020

Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression

artículo científico publicado en 2006

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

artículo científico publicado en 2018

Decade in review-haematological cancer: advances in biology and therapy

artículo científico publicado en 2014

Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

scientific article published on 23 April 2020

Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies.

artículo científico publicado en 2018

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression

article

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

artículo científico

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

artículo científico publicado en 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma

artículo científico publicado en 2006

Dermatologic side effects of thalidomide in patients with multiple myeloma.

artículo científico publicado en 2003

Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement

scientific article published on 13 December 2019

Development of early treatment strategies for high-risk myeloma precursor disease in the future

artículo científico publicado en 2011

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

artículo científico publicado en 2019

Dexamethasone and the risk for adrenal suppression in multiple myeloma

artículo científico publicado en 2009

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

artículo científico

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

artículo científico publicado en 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

artículo científico publicado en 2010

Diagnosis of Smoldering Multiple Myeloma ⬇️

artículo científico publicado el 4 de agosto de 2011

Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia

artículo científico publicado en 2002

Diagnostic evaluation of monoclonal gammopathy of undetermined significance

scientific article published on 01 December 2013

Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry

article

Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma

artículo científico publicado en 2013

Differential expression of vascular endothelial growth factors and their receptors in multiple myeloma.

artículo científico publicado en 2006

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

article by Eli Muchtar et al published 12 March 2018 in Amyloid

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

artículo científico publicado en 2010

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.

artículo científico publicado en 2018

Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients

artículo científico publicado en 2009

Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites

artículo científico publicado en 2011

Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.

artículo científico publicado en 2011

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

artículo científico publicado en 2016

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

artículo científico publicado en 2011

Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia

artículo científico publicado en 2003

Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control study

artículo científico publicado en 2004

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

artículo científico publicado en 2003

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

artículo científico publicado en 2004

Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone

article

Effects of bortezomib on bone disease in multiple myeloma

artículo científico publicado en 2009

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

artículo científico publicado en 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

artículo científico publicado en 2017

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

artículo científico publicado en 2011

Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma

artículo científico publicado en 2011

Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis

artículo científico publicado en 2015

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

artículo científico publicado en 2017

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

artículo científico publicado en 2001

Eliminating the complete response penalty from myeloma response criteria

artículo científico publicado en 2008

Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays

artículo científico publicado en 2006

Elucidating disparities across racial and ethnic groups in multiple myeloma patients

artículo científico publicado en 2012

Emerging therapies for multiple myeloma

artículo científico publicado en 2009

Empiricism and rationalism in medicine: can 2 competing philosophies coexist to improve the quality of medical care?

artículo científico publicado en 2013

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

artículo científico publicado en 2020

Epidemiology of the plasma-cell disorders

artículo científico publicado en 2007

Erratum: International uniform response criteria for multiple myeloma

scholarly article published in Leukemia

Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis

scholarly article published in Leukemia

Evaluation and monitoring of response to therapy in multiple myeloma

artículo científico publicado en 2005

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

scientific article published on 13 July 2012

Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie

artículo científico publicado en 2010

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study

artículo científico publicado en 2009

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

artículo científico publicado en 2016

Expression of VEGF and its receptors by myeloma cells

artículo científico publicado en 2003

Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

scientific article published on 09 August 2007

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial

artículo científico publicado en 2006

Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics

artículo científico publicado en 2012

Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review

artículo científico publicado en 2018

Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis

scientific article published on 01 October 2000

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system

artículo científico publicado en 2005

Fracture risk in monoclonal gammopathy of undetermined significance

artículo científico publicado en 2004

Fracture risk with multiple myeloma: a population-based study

scientific article published on 29 November 2004

Free light-chains and renal disorders: when small is worse – Authors' reply

scientific article published in The Lancet

Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib

scientific article published on 05 June 2006

From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention

artículo científico publicado en 2011

Front-line treatment in younger patients with multiple myeloma

artículo científico publicado en 2009

Genetic aberrations and survival in plasma cell leukemia

artículo científico publicado en 2008

Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

artículo científico publicado en 2008

Genomic abnormalities in monoclonal gammopathy of undetermined significance

scientific article published on 01 August 2002

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

artículo científico publicado en 2015

Granulomatous Vasculitis Associated With Herpes Virus ⬇️

artículo científico publicado el 1 de abril de 1998

Guidelines for determination of the number of prior lines of therapy in multiple myeloma.

artículo científico publicado en 2015

Haematological cancer: Lenalidomide maintenance--perils of a premature denouement

artículo científico publicado en 2012

Haematological cancer: Treatment of smoldering multiple myeloma.

artículo científico publicado en 2013

Helicobacter pylori infection and monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2002

Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits

artículo científico

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

artículo científico publicado en 2017

Hematology: Trials and tribulations in primary CNS lymphoma

scientific article published on 01 March 2010

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

scientific article published on 29 October 2019

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.

artículo científico publicado en 2012

High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa

artículo científico publicado en 2011

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis

scientific article published on 08 January 2014

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

artículo científico publicado en 2011

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma

artículo científico publicado en 2019

How I manage monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2017

How best to use new therapies in multiple myeloma

scientific article published on April 2010

IV. Initial treatment of multiple myeloma ⬇️

artículo científico publicado el 1 de junio de 2013

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia

artículo científico publicado en 2009

Identification of genes modulated in multiple myeloma using genetically identical twin samples

artículo científico publicado en 2003

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

artículo científico publicado en 2009

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

scientific article published on 28 November 2019

IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Waldenström's Macroglobulinemia (SWM)

artículo científico publicado en 2011

IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia

artículo científico publicado en 2009

Immunoglobulin D amyloidosis: a distinct entity

artículo científico publicado en 2011

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

artículo científico publicado en 2008

Immunoglobulin free light chains and solitary plasmacytoma of bone

artículo científico publicado en 2006

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias

scientific article published on 02 September 2014

Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia

artículo científico publicado en 2013

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

artículo científico publicado en 2016

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

artículo científico publicado en 2016

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Impact of acquired del(17p) in multiple myeloma

artículo científico publicado en 2019

Impact of additional cytoreduction following autologous SCT in multiple myeloma.

scientific article published on 16 June 2008

Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.

artículo científico publicado en 2017

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

artículo científico publicado en 2015

Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2009

Impact of early relapse after auto-SCT for multiple myeloma.

artículo científico publicado en 2008

Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone

artículo científico publicado en 2011

Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.

artículo científico publicado en 2011

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

artículo científico publicado en 2017

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

artículo científico publicado en 2020

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

artículo científico publicado en 2010

Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.

artículo científico publicado en 2008

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

artículo científico publicado en 2013

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

artículo científico publicado en 2017

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

artículo científico publicado en 2009

Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma

artículo científico publicado en 2009

Impaired myocardial perfusion reserve in experimental hypercholesterolemia is independent of myocardial neovascularization

artículo científico publicado en 2007

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

artículo científico publicado en 2020

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

artículo científico publicado en 2020

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

artículo científico publicado en 2013

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

artículo científico publicado en 2017

Improved survival in multiple myeloma and the impact of novel therapies

artículo científico publicado en 2007

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2015

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

artículo científico publicado en 2008

Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma.

artículo científico publicado en 2012

In Reply

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

In reply

In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma

artículo científico publicado en 2020

Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

artículo científico publicado en 2011

Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition

artículo científico publicado en 2012

Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades

artículo científico publicado en 2004

Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma

artículo científico publicado en 2011

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

scientific article published on 07 April 2020

Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III.

artículo científico publicado en 2016

Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma

artículo científico publicado en 2012

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

artículo científico publicado en 2009

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

artículo científico publicado en 2018

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

artículo científico publicado en 2009

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

artículo científico publicado en 2016

Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma

artículo científico publicado en 2014

Initial genome sequencing and analysis of multiple myeloma

artículo científico publicado en 2011

International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

artículo científico publicado en 2016

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation

artículo científico publicado en 2011

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

artículo científico publicado en 2016

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

artículo científico publicado en 2014

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

artículo científico publicado en 2008

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

artículo científico publicado en 2013

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

artículo científico publicado en 2020

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

artículo científico publicado en 2014

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

scientific article published on 01 June 2019

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

artículo científico publicado en 2009

International uniform response criteria for multiple myeloma.

artículo científico publicado en 2006

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

artículo científico publicado en 2016

Introduction to a cancer symposium for the practitioner

scientific article published on 01 August 2005

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

artículo científico publicado en 2019

Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors

scientific article published on 01 February 2017

Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.

artículo científico publicado en 2017

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

artículo científico publicado en 2019

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders

scientific article published on 30 May 2018

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

artículo científico publicado en 2015

Laboratory persistence and clinical progression of small monoclonal abnormalities

artículo científico publicado en 2012

Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study

scholarly article by Joseph Mikhael et al published 29 August 2018 in Blood Cancer Journal

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

artículo científico publicado en 2007

Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure

artículo científico publicado en 2008

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

artículo científico publicado en 2009

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

artículo científico publicado en 2010

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

artículo científico publicado en 2009

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

artículo científico publicado en 2011

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

artículo científico publicado en 2012

Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma

scientific article published on 01 September 2000

Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

artículo científico publicado en 2018

Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies

artículo científico publicado en 2011

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy

artículo científico publicado en 2014

Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later

artículo científico publicado en 2004

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

artículo científico publicado en 2003

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

artículo científico publicado en 2003

Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation

artículo científico publicado en 2012

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

artículo científico publicado en 2016

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

artículo científico publicado en 2013

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

artículo científico publicado en 2020

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

artículo científico publicado en 2007

Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

artículo científico publicado en 2010

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous

scientific article published on 11 May 2020

MAIA under the microscope - bringing trial design into focus

artículo científico publicado en 2019

MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.

artículo científico publicado en 2011

MYC dysregulation in the progression of multiple myeloma

artículo científico publicado en 2019

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

artículo científico publicado en 2017

Macro-quest

artículo científico publicado en 2015

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

artículo científico publicado en 2011

Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

artículo científico publicado en 2011

Management of newly diagnosed myeloma.

artículo científico publicado en 2007

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

artículo científico

Management of thalidomide toxicity

artículo científico publicado en 2003

Management of treatment-emergent peripheral neuropathy in multiple myeloma.

artículo científico publicado en 2011

Many facets of bortezomib resistance/susceptibility

artículo científico publicado en 2008

Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma

scientific article published on 16 December 2019

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

artículo científico publicado en 2006

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis

artículo científico publicado en 2011

Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma

artículo científico publicado en 2015

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

artículo científico publicado en 2020

Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation

article

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

artículo científico publicado en 2009

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

article

Molecular signatures of multiple myeloma progression through single cell RNA-Seq

artículo científico publicado en 2019

Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays

artículo científico publicado en 2014

Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

artículo científico publicado en 2015

Monoclonal gammopathies of undetermined significance

scientific article published on 01 September 2002

Monoclonal gammopathies of undetermined significance

scientific article published on 01 January 2005

Monoclonal gammopathy of undetermined significance

artículo científico publicado en 2005

Monoclonal gammopathy of undetermined significance

article

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

artículo científico publicado en 2010

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

artículo científico publicado en 2009

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

artículo científico publicado en 2007

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

artículo científico publicado en 2007

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

scientific article published on 01 April 2010

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

artículo científico publicado en 2014

Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression

scientific article published on December 2007

Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment

artículo científico publicado en 2006

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

artículo científico publicado en 2019

Monoclonal gammopathy-associated proliferative glomerulonephritis

artículo científico publicado en 2013

Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma

artículo científico publicado en 2008

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

Multiple Myeloma: 2020 update on Diagnosis, Risk-stratification and Management

artículo científico publicado en 2020

Multiple Myeloma: Diagnosis and Treatment.

artículo científico publicado en 2016

Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001.

artículo científico publicado en 2014

Multiple myeloma

artículo científico publicado en 2008

Multiple myeloma

artículo científico publicado en 2009

Multiple myeloma after kidney transplantation

artículo científico publicado en 2014

Multiple myeloma and the road to personalised medicine ⬇️

artículo científico publicado el 12 de junio de 2011

Multiple myeloma current treatment algorithms

artículo científico publicado en 2020

Multiple myeloma in 2016: Fresh perspectives on treatment and moments of clarity

artículo científico publicado en 2017

Multiple myeloma--translation of trial results into reality

artículo científico publicado en 2016

Multiple myeloma.

artículo científico publicado en 2004

Multiple myeloma: 2011 update on diagnosis, risk‐stratification, and management ⬇️

artículo científico publicado el 1 de enero de 2011

Multiple myeloma: 2012 update on diagnosis, risk‐stratification, and management ⬇️

artículo científico publicado el 1 de enero de 2012

Multiple myeloma: 2013 update on diagnosis, risk‐stratification, and management ⬇️

artículo científico publicado el 1 de marzo de 2013

Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management

scholarly article by S. Vincent Rajkumar published 16 August 2018 in American Journal of Hematology

Multiple myeloma: chemotherapy or transplantation in the era of new drugs.

scientific article published on 23 March 2010

Multiple myeloma: diagnosis and treatment

scientific article published on 01 October 2005

Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.

artículo científico publicado en 2007

Myeloma and the newly diagnosed patient: a focus on treatment and management

artículo científico publicado en 2002

Myelomatous Involvement of the Central Nervous System

artículo científico publicado en 2016

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2016

Natural history of amyloidosis isolated to fat and bone marrow aspirate

artículo científico publicado en 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Natural history of t(11;14) multiple myeloma

artículo científico publicado en 2017

Natural history of thromboembolism in AL amyloidosis

artículo científico publicado en 2006

New developments in diagnosis, prognosis, and assessment of response in multiple myeloma

artículo científico publicado en 2016

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

artículo científico publicado en 2014

Next-generation multiple myeloma treatment: a pharmacoeconomic perspective

artículo científico publicado en 2016

Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk.

artículo científico publicado en 2018

Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma

artículo científico publicado en 2007

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

artículo científico publicado en 2010

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma

artículo científico publicado en 2016

Optimising bortezomib in newly diagnosed multiple myeloma ⬇️

artículo científico publicado el 23 de agosto de 2010

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

artículo científico publicado en 2018

Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders

artículo científico publicado en 2008

Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis

Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-up

artículo científico publicado en 2016

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant

artículo científico publicado en 2014

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Outcomes of patients with POEMS syndrome treated initially with radiation

artículo científico publicado en 2013

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

artículo científico publicado en 2016

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

artículo científico publicado en 2015

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma

scientific article published on 16 December 2020

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2019

Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis

artículo científico publicado en 2020

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

artículo científico publicado en 2017

POEMS syndrome: definitions and long-term outcome

artículo científico publicado en 2002

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study

artículo científico publicado en 2009

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

artículo científico publicado en 2015

Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.

artículo científico publicado en 1998

Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.

artículo científico publicado en 1999

Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.

artículo científico publicado en 1998

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

artículo científico publicado en 2015

Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.

artículo científico publicado en 1999

Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group

artículo científico publicado en 2009

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

artículo científico publicado en 2005

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

artículo científico publicado en 2018

Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma

artículo científico publicado en 2003

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma

artículo científico publicado en 1999

Plasmacytoma of the Temporal Bone, a Great Imitator: Report of Seven Cases and Comprehensive Review of the Literature

artículo científico publicado en 2017

Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms

artículo científico publicado en 2012

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies

scholarly article by Shaji Kumar et al published 17 May 2019 in Blood Cancer Journal

Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma

artículo científico publicado en 2011

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

artículo científico publicado en 2010

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

artículo científico publicado en 2009

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

artículo científico publicado en 2011

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

artículo científico publicado en 2017

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

artículo científico

Pomalidomide: a new IMiD with remarkable activity in both multiple myeloma and myelofibrosis

artículo científico publicado en 2010

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma.

artículo científico

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis

artículo científico publicado en 2003

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.

artículo científico publicado en 2015

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

artículo científico publicado en 2015

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

artículo científico publicado en 2017

Predictors of short-term survival in Waldenström Macroglobulinemia

artículo científico publicado en 2020

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

scientific article published on 02 October 2018

Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2004

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

artículo científico publicado en 2017

Prevalence and monitoring of oligosecretory myeloma

scientific article published on 01 August 2012

Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

artículo científico publicado en 2017

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

artículo científico publicado en 2010

Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana

Prevalence of monoclonal gammopathy of undetermined significance

artículo científico publicado en 2006

Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana

artículo científico publicado en 2007

Prevalence of monoclonal gammopathy of undetermined significance: a systematic review

artículo científico publicado en 2010

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.

artículo científico publicado en 2017

Prevalence, incidence and survival of smoldering multiple myeloma in the United States

artículo científico publicado en 2016

Prevention of progression in monoclonal gammopathy of undetermined significance

artículo científico publicado en 2009

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

artículo científico publicado en 2007

Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia

artículo científico publicado en 2009

Preventive strategies in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma ⬇️

artículo científico publicado el 10 de abril de 2012

Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy

artículo científico publicado en 2006

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Primary systemic amyloidosis with delayed progression to multiple myeloma

artículo científico publicado en 1998

Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy

artículo científico publicado en 1998

Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance

article

Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance

artículo científico publicado en 2005

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

artículo científico publicado en 2017

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

artículo científico publicado en 2006

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

artículo científico publicado en 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

artículo científico publicado en 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of angiogenesis in solitary bone plasmacytoma

artículo científico publicado en 2002

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.

artículo científico publicado en 2004

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

artículo científico publicado en 2006

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

artículo científico publicado en 2019

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

artículo científico publicado en 2008

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

artículo científico publicado en 2004

Progress in Myeloma - A Monoclonal Breakthrough

artículo científico publicado en 2016

Progression in smoldering Waldenstrom macroglobulinemia: long-term results

artículo científico publicado en 2012

Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.

artículo científico publicado en 2002

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing

artículo científico publicado en 2018

Proteasome inhibition as a novel therapeutic target in human cancer.

artículo científico publicado en 2005

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

scientific article published on 01 February 2019

Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

artículo científico publicado en 2016

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

artículo científico publicado en 2014

Quantification of clonal circulating plasma cells in relapsed multiple myeloma

artículo científico publicado en 2014

R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.

artículo científico publicado en 2008

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

artículo científico publicado en 2015

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

scientific article published on 13 February 2015

Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey

artículo científico publicado en 2014

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

artículo científico publicado en 2019

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

artículo científico publicado en 2016

Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

scientific article published on 29 July 2016

Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

artículo científico publicado en 2012

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method

scientific article published on 08 January 2019

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

artículo científico publicado en 2011

Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group

artículo científico publicado en 2018

Redefining myeloma

artículo científico publicado en 2012

Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival

artículo científico publicado en 2011

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

artículo científico publicado en 2020

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

artículo científico publicado en 2018

Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma

artículo científico publicado en 2010

Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.

artículo científico publicado en 2013

Remission of disseminated cancer after systemic oncolytic virotherapy

artículo científico publicado en 2014

Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group

artículo científico publicado en 2010

Renal improvement in myeloma with bortezomib plus plasma exchange

artículo científico publicado en 2011

Reply to Castillo et al.

artículo científico publicado en 2018

Reply to N. Biran et al

scientific article published on 11 March 2020

Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myeloma

artículo científico publicado en 2010

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

artículo científico publicado en 2003

Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'

artículo científico publicado en 2018

Response to rituximab in patients with type II cryoglobulinemia

artículo científico publicado en 2006

Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy

artículo científico publicado en 2011

Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels

artículo científico publicado en 2013

Review of 1027 patients with newly diagnosed multiple myeloma

artículo científico publicado en 2003

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

artículo científico publicado en 2015

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

scholarly article by Praful Ravi et al published 15 November 2018 in Blood Cancer Journal

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

artículo científico publicado en 2012

Revisiting complete response in light chain amyloidosis

scientific article published on 26 November 2019

Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics

artículo científico publicado en 2018

Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients

artículo científico publicado en 2013

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study ⬇️

artículo científico publicado el 29 de julio de 2011

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

artículo científico publicado en 2018

Robert A. Kyle, MD: Lessons From a Legend

artículo científico publicado en 2019

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

artículo científico publicado en 2017

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

artículo científico publicado en 2015

Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma

artículo científico publicado en 2005

Screening panels for detection of monoclonal gammopathies

artículo científico publicado en 2009

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

artículo científico publicado en 2016

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

scientific article published on 01 April 2018

Second to none

artículo científico publicado en 2012

Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance.

artículo científico

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

artículo científico publicado en 2004

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

artículo científico publicado en 2012

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

artículo científico publicado en 2005

Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome

artículo científico publicado en 2010

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

artículo científico publicado en 2010

Serum uric acid: novel prognostic factor in primary systemic amyloidosis

artículo científico publicado en 2008

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

artículo científico publicado en 2004

Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma

artículo científico publicado en 2012

Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma

artículo científico publicado en 2016

Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations

artículo científico publicado en 2009

Smoldering Myeloma and the Art of War

artículo científico publicado en 2020

Smoldering multiple myeloma requiring treatment: time for a new definition?

artículo científico publicado en 2013

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

artículo científico publicado en 2015

Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs

artículo científico publicado en 2009

Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.

artículo científico publicado en 2011

Spectrum of manifestations of monoclonal gammopathy-associated renal lesions

artículo científico publicado en 2016

Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis

artículo científico publicado en 2016

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation

artículo científico publicado en 2005

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

artículo científico publicado en 2004

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.

artículo científico publicado en 2012

Surrogate endpoints in randomised controlled trials: a reality check

artículo científico publicado en 2019

Survival and years of life lost in different age cohorts of patients with multiple myeloma

artículo científico publicado en 2010

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

artículo científico publicado en 2016

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2013

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma

scientific article published on 06 February 2019

Thalidomid: current role in the treatment of non-plasma cell malignancies.

artículo científico publicado en 2004

Thalidomide and dexamethasone: therapy for multiple myeloma.

artículo científico publicado en 2005

Thalidomide and lenalidomide in the treatment of multiple myeloma

artículo científico publicado en 2006

Thalidomide as an anti-cancer agent.

artículo científico publicado en 2002

Thalidomide in the treatment of plasma cell malignancies

artículo científico publicado en 2001

Thalidomide in the treatment of relapsed multiple myeloma

scientific article published on 01 September 2000

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias

artículo científico publicado en 2020

The Case for Masks: Health Care Workers Can Benefit Too

artículo científico publicado en 2020

The High Cost of Cancer Drugs and What We Can Do About It ⬇️

artículo científico publicado el 1 de octubre de 2012

The High Cost of Insulin in the United States: An Urgent Call to Action

artículo científico publicado en 2020

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

artículo científico publicado en 2006

The clinical significance of cereblon expression in multiple myeloma

artículo científico publicado en 2013

The current status of minimal residual disease assessment in myeloma

artículo científico publicado en 2014

The definition of IgM multiple myeloma

scholarly article by Steven R. Schuster et al published 14 July 2011 in American Journal of Hematology

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

artículo científico publicado en 2019

The high cost of prescription drugs: causes and solutions

artículo científico publicado en 2020

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

artículo científico publicado en 2015

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma

scientific article published on 29 July 2009

The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response

scientific article published on 30 January 2018

The multiple myelomas - current concepts in cytogenetic classification and therapy.

artículo científico publicado en 2018

The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2016

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

artículo científico publicado en 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

artículo científico publicado en 2016

The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma

artículo científico publicado en 2008

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG)

scholarly article by Charalampia Kyriakou et al published 26 February 2019 in Blood Cancer Journal

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

artículo científico publicado en 2008

The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Onc

artículo científico publicado en 2009

The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome

scientific article published on 31 August 2011

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

artículo científico publicado en 2017

Thromboembolic events with lenalidomide-based therapy for multiple myeloma

artículo científico publicado en 2008

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.

artículo científico publicado en 2006

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

artículo científico publicado en 2018

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

artículo científico publicado en 2009

Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis

artículo científico publicado en 2001

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

artículo científico

Treatment of multiple myeloma

artículo científico publicado en 2011

Treatment of multiple myeloma: a comprehensive review

artículo científico publicado en 2009

Treatment of multiple myeloma: an emphasis on new developments

artículo científico publicado en 2006

Treatment of myeloma: cure vs control

artículo científico publicado en 2008

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

artículo científico publicado en 2007

Treatment of newly diagnosed myeloma.

artículo científico publicado en 2008

Treatment of plasma cell dyscrasias with lenalidomide

artículo científico publicado en 2008

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

article

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

artículo científico publicado en 2017

Treatment patterns and outcomes in elderly patients with multiple myeloma

artículo científico publicado en 2012

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

artículo científico publicado en 2003

Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies

artículo científico publicado en 2013

Trends and outcomes of modern staging of solitary plasmacytoma of bone

artículo científico publicado en 2012

Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012.

artículo científico publicado en 2015

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

artículo científico publicado en 2014

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

artículo científico publicado en 2012

Two types of amyloidosis presenting in a single patient: a case series

artículo científico publicado en 2019

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

artículo científico publicado en 2013

Update on risk stratification and treatment of newly diagnosed multiple myeloma.

artículo científico

Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases

artículo científico publicado en 2012

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

artículo científico publicado en 2020

Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population

artículo científico publicado en 2012

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2018

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

artículo científico publicado en 2020

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

artículo científico publicado en 2015

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

artículo científico publicado en 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

artículo científico publicado en 2019

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

artículo científico publicado en 2020

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis

scientific article published on 08 January 2020

Waldenström's macroglobulinemia

artículo científico publicado en 2000

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group.

artículo científico publicado en 2017

Why are cancer drugs so expensive in the United States, and what are the solutions?

artículo científico

Will the real myeloma please stand up?

artículo científico publicado en 2013

Zoledronic acid in myeloma: MRC Myeloma IX ⬇️

artículo científico publicado el 3 de diciembre de 2010

c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma

scientific article published on 07 March 2020

“Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?” ⬇️

artículo científico publicado el 18 de marzo de 2012

Lista de obras de S. Vincent Rajkumar

6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

A classic case of amyloid cardiomyopathy

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

A phase 2 study of bortezomib in relapsed, refractory myeloma

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

A phase II trial of imatinib in patients with refractory/relapsed myeloma

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans.

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma.

A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies

A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.

A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence

Advances in the treatment of amyloidosis

Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration

Anemia After Orchiectomy

Angiogenesis in Waldenstrom's macroglobulinemia

Angiogenesis in multiple myeloma

Anti-CD20 monoclonal antibody therapy in multiple myeloma.

Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.

Approach to the treatment of multiple myeloma: a clash of philosophies.

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy

Autologous stem cell transplant for multiple myeloma patients 70 years or older

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma

BiTEing the Tumor

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

Bone marrow angiogenesis and circulating plasma cells in multiple myeloma

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis

Bone marrow angiogenesis in multiple myeloma: effect of therapy

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

Bortezomib combination therapy in multiple myeloma

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

Bortezomib-induced acute interstitial nephritis

CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations

Cancer symposium for the practitioner: introduction to solid tumors

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature

Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma.

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

Characterization and prognostic implication of delayed complete response in AL amyloidosis

Chemotherapy-associated thrombosis.

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

Circulating serum free light chains as predictive markers of AIDS-related lymphoma

Clarification of the definition of complete response in multiple myeloma